Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?

Documenti analoghi

• Response to “Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?”
  di: Ruan, Yibing, et al.
  Pubblicazione: (2016)
• The Dual PI3K/mToR Inhibitor Omipalisib/GSK2126458 Inhibits Clonogenic Growth in Oncogenically-transformed Cells from Neurocutaneous Melanocytosis
  di: BASU, DIPANJAN, et al.
  Pubblicazione: (2018)
• Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway
  di: Basu, Dipanjan, et al.
  Pubblicazione: (2016)
• Pluripotency markers are differentially induced by IGF1 and bFGF in cells from patients’ lesions of large/giant congenital melanocytic nevi
  di: Basu, Dipanjan, et al.
  Pubblicazione: (2019)
• Pluripotency markers are differentially induced by IGF1 and bFGF in cells from patients’ lesions of large/giant congenital melanocytic nevi
  di: Dipanjan Basu, et al.
  Pubblicazione: (2019-01-01)